Strongbridge Biopharma plc
SBBP · NASDAQ
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $88 | $57 | $122 | $58 |
| Short-Term Investments | $0 | $21 | $0 | $0 |
| Receivables | $3 | $2 | $2 | $2 |
| Inventory | $1 | $2 | $4 | $1 |
| Other Curr. Assets | $1 | $1 | $4 | $1 |
| Total Curr. Assets | $92 | $84 | $132 | $61 |
| Property Plant & Equip (Net) | $1 | $1 | $0 | $0 |
| Goodwill | $7 | $7 | $7 | $7 |
| Intangibles | $20 | $25 | $30 | $35 |
| Long-Term Investments | $0 | $21 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | -$20 | $0 | $1 |
| Total NC Assets | $29 | $34 | $38 | $43 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $121 | $118 | $170 | $104 |
| Liabilities | – | – | – | – |
| Payables | $1 | $3 | $1 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $19 | $21 | $16 | $11 |
| Total Curr. Liab. | $21 | $24 | $17 | $12 |
| LT Debt | $17 | $0 | $0 | $38 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $17 | $21 | $40 | $66 |
| Total NC Liab. | $34 | $21 | $40 | $103 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $55 | $45 | $57 | $116 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $0 |
| Retained Earnings | -$306 | -$260 | -$211 | -$243 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $370 | $332 | $323 | $231 |
| Total Equity | $66 | $72 | $113 | -$12 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $121 | $118 | $170 | $104 |
| Net Debt | -$70 | -$57 | -$122 | -$20 |